| Product Code: ETC8292773 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico mRNA Vaccine and Therapeutics Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 Mexico mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Mexico mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government investments in healthcare infrastructure and research and development. |
4.2.2 Rising prevalence of infectious diseases driving the demand for mRNA vaccines and therapeutics. |
4.2.3 Growing awareness and acceptance of mRNA technology in Mexico's healthcare sector. |
4.3 Market Restraints |
4.3.1 High initial costs of developing and manufacturing mRNA vaccines and therapeutics. |
4.3.2 Regulatory challenges and approval processes for mRNA products in Mexico. |
5 Mexico mRNA Vaccine and Therapeutics Market Trends |
6 Mexico mRNA Vaccine and Therapeutics Market, By Types |
6.1 Mexico mRNA Vaccine and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F |
6.1.4 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F |
6.2 Mexico mRNA Vaccine and Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.5 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Mexico mRNA Vaccine and Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.3.3 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.5 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Mexico mRNA Vaccine and Therapeutics Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F |
6.4.3 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 Mexico mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics |
7.1 Mexico mRNA Vaccine and Therapeutics Market Export to Major Countries |
7.2 Mexico mRNA Vaccine and Therapeutics Market Imports from Major Countries |
8 Mexico mRNA Vaccine and Therapeutics Market Key Performance Indicators |
8.1 Research and development funding allocated by the Mexican government towards mRNA vaccine and therapeutics. |
8.2 Number of clinical trials conducted for mRNA vaccines and therapeutics in Mexico. |
8.3 Adoption rate of mRNA technology in healthcare facilities and among healthcare professionals in Mexico. |
9 Mexico mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
9.1 Mexico mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Mexico mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Mexico mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Mexico mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Mexico mRNA Vaccine and Therapeutics Market - Competitive Landscape |
10.1 Mexico mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Mexico mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here